Rallybio Corporation
RLYB
$16.99
$0.030.18%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 627.48% | -41.46% | -136.54% | 265.06% | -2.80% |
| Total Depreciation and Amortization | -33.33% | 0.00% | -91.43% | 34.62% | -7.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -22.24% | -16.99% | 103.16% | -1,325.17% | -22.52% |
| Change in Net Operating Assets | 784.91% | -153.75% | 141.60% | -163.33% | 85.25% |
| Cash from Operations | 675.57% | -70.51% | 28.56% | 21.83% | 17.89% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -69.27% | 356.05% | -86.57% | 863.00% | -72.61% |
| Cash from Investing | -69.27% | 356.05% | -86.57% | 863.00% | -72.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4,266.67% | -50.00% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4,266.67% | -50.00% | -- | -100.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 419.40% | 1,426.87% | -103.30% | 525.14% | -708.90% |